argenx SE (ARGX) Financials

ARGX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 ? ?
Dec. 31, 2025 8.7 billion 1.4 billion
Sept. 30, 2025 ? ?
June 30, 2025 7.2 billion 1.1 billion

ARGX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 ? ?
Dec. 31, 2025 406.9 million ?
Sept. 30, 2025 ? ?
June 30, 2025 432.6 million ?

ARGX Net Income

No data available :(

ARGX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 - - -
Dec. 31, 2025 4.4 billion 36.3 million 36.3 million
Sept. 30, 2025 - - -
June 30, 2025 3.9 billion - 35.6 million

ARGX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 ?
Dec. 31, 2025 66.2 million
Sept. 30, 2025 ?
June 30, 2025 65.7 million

ARGX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 443.0 million 355.0 million -
Dec. 31, 2025 900214 717.8 million 760.4 million -
Sept. 30, 2025 - 355.7 million 336.3 million -
June 30, 2025 5.2 million 636.8 million 602.4 million 178.2 million

ARGX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.3 billion 121.0 million
Dec. 31, 2025 2.4 billion 269.6 million
Sept. 30, 2025 1.1 billion 109.4 million
June 30, 2025 1.8 billion 201.7 million

ARGX

Price: $891.32

52 week price:
510.06
934.62

Earnings Per Share: 22.54 USD

P/E Ratio: 36.08

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: Netherlands

Volume: 205974

Ebitda: -24.6 million

Market Capitalization: 52.1 billion

Links: